Researchers analysed ash residues from two incense burners found in Pompeii and a nearby villa. They used modern laboratory methods and biomolecular tests to study the dark remains inside the vessels.
The analyses identified both local plant remains and materials that came from farther away. In one burner the team found an exotic tree resin probably from tropical Africa or Asia. Molecular tests also detected a grape product in one incense burner, which fits with known Roman use of wine in rituals.
Difficult words
- analyse — look at something carefully to learn about itanalysed
- residue — small part left after a process or useresidues
- incense burner — vessel used to burn aromatic materialsincense burners
- biomolecular — about molecules in living things
- exotic — from far away and not common locally
- resin — sticky plant substance often from trees
- detect — to find or notice something presentdetected
- ritual — a traditional action done for a purposerituals
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why do you think people in ancient Rome used wine in rituals?
- Have you ever seen an incense burner? Where did you see it?
- Does it surprise you that materials came from far away to Pompeii? Why or why not?
Related articles
Tanzania fights rabies with mass dog vaccination
Tanzania is working to stop human rabies by vaccinating dogs, improving surveillance and keeping vaccines cold. High vaccine costs, remote villages and lack of electricity remain challenges, but local and international efforts are growing.
Indigenous leader Dzoodzo Baniwa wins climate award
Dzoodzo Baniwa, from the Alto Río Negro territory in Amazonas, won a Bunge Foundation award for work on the climate emergency and practical agricultural science solutions. The prize highlights links between indigenous knowledge and scientific practice.
New oral drug approved for sleeping sickness
European regulators approved Acoziborole, a single-dose oral treatment for sleeping sickness after successful trials in the DRC and Guinea. Sanofi will donate doses to WHO, but national approvals and vector control are still needed to reach elimination goals.